Dr Caio Max Rocha Lima speaks to ecancer about a study carried out by the Dutch group to investigate the neoadjuvant use of gemcitabine for pancreatic and hepatobiliary cancer.
Initially, he explains the background and methodology of the study. Dr Lima then discusses the results of this study.
To conclude, he mentions the impact these results can have on the future treatment of pancreatic and hepatobiliary cancer.
Watch the meeting in full by following the links below: